U.S. Sanctions Hinder Cuba's Healthcare and Biotech Sectors, Says Valdes-Sosa
Mitchell Valdes-Sosa, a key figure in Cuba’s biotechnology strategy, stated that U.S. sanctions are systematically aimed at cutting off income to Cuba. He asserted that these sanctions are significantly impairing Cuba's healthcare and biotechnology industries by restricting access to income, supplies, and energy. Despite facing increasing shortages and declining health outcomes, Cuba is reportedly prioritizing crucial research and fostering international collaboration to sustain its biotechnology sector.
Mitchell Valdes-Sosa, an architect of Cuba’s biotechnology strategy, has stated that U.S. government policy aims to systematically cut off all sources of income for Cuba.
Valdes-Sosa indicated that U.S. sanctions are severely affecting Cuba’s healthcare and biotech sectors. He attributed this impact to the choking off of income, essential supplies, and energy.
Despite an environment of worsening shortages and health outcomes, Cuba is reportedly focusing on key research initiatives. The nation is also expanding international collaboration efforts to ensure the continued operation of its biotechnology industry.
According to Mitchell Valdes-Sosa, the U.S. government's policy is to systematically cut off any source of income to Cuba. (Source: The Hindu International)
